1. Home
  2. VRAX vs MBOT Comparison

VRAX vs MBOT Comparison

Compare VRAX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$0.61

Market Cap

972.3K

Sector

Health Care

ML Signal

N/A

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

N/A

Current Price

$0.97

Market Cap

73.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRAX
MBOT
Founded
2013
2010
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
972.3K
73.2M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
VRAX
MBOT
Price
$0.61
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $5.38
AVG Volume (30 Days)
537.1K
★ 861.4K
Earning Date
11-20-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 60.27
EPS
★ N/A
N/A
Revenue
N/A
★ $116,887.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$377.83
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.93
52 Week High
$13.19
$2.86

Technical Indicators

Market Signals
Indicator
VRAX
MBOT
Relative Strength Index (RSI) 21.31 39.89
Support Level $0.15 N/A
Resistance Level $1.57 $1.18
Average True Range (ATR) 0.17 0.08
MACD -0.02 0.01
Stochastic Oscillator 10.47 10.54

Price Performance

Historical Comparison
VRAX
MBOT

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Share on Social Networks: